PATENT CLAIM ANALYSIS

Application Number: 16014167
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "561000"]

Abstract:
The present application relates to combination treatments for bacterial infections. For example, the application relates to the use of one or more β-lactam antibiotics and one or more compounds of Formula I: (I) for treatment of a metallo-β-lactamase-expressing bacterial infection or a disease, disorder or condition arising from a metallo-β-lactamase-expressing bacterial infection.

Claim (Index 17):
The method of  claim 15 , wherein the metallo-\u03b2-lactamase-expressing bacterium is at least one bacterium belonging to the family Enterobacteriaceae,  Acinetobacter  or  Pseudomonas.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 94.0
- Lexical Diversity: 1.55263
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14888764', '15278916', '14694550', '15463952', '15516096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8172712691760413
- 35 USC 102 Novelty (BERT): 0.6103370543572195
- Combined Prediction Score: 0.7965778476941592
- Mean Citation Score: 425.070208
- Max Citation Score: 614.0642
- Similarity Product: 466.1581803086639

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test